|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/435 | |||
| A61K 31/445 | |||
| A61P 37/00 |
| (11) | Patento numeris | 3385263 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18171833.9 |
| Europos patento paraiškos padavimo data | 2013-06-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261657360 P | 2012-06-08 | US |
| (72) |
HOPKINS, Brian T., US
CONLON, Patrick, US
CHAN, Timothy R., US
JENKINS, Tracy J., US
CAI, Xiongwei, US
HUMORA, Michael, US
SHI, Xianglin, US
MILLER, Ross A., US
THOMPSON, Andrew, US
|
| (73) |
Sunesis Pharmaceuticals, Inc.,
395 Oyster Point Blvd., Suite 400, South San Francisco, CA 94080,
US
Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, US |
| (54) | PYRIMIDINYL TYROSINE KINASE INHIBITORS |
| PYRIMIDINYL TYROSINE KINASE INHIBITORS |